Diabetes Technology and Therapeutics : Impact Factor & More
eISSN: 1557-8593pISSN: 1520-9156
Share this on:
Key Metrics
CiteScore 
10.3
Eigenfactor
0.005 - 0.01
H-Index
97
Impact Factor
5 - 10
SJR
Q1Endocrinology
SNIP
1.97
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Diabetes Technology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Diabetes Technology and Therapeutics
Normal Reference Range for Glucose Rates of Change in Nondiabetic Individuals Using Continuous Glucose Monitoring.
- 21 Nov 2025
- Diabetes technology & therapeutics
Glucose Responses to Aerobic Exercise Are Influenced by Glucose Levels before the Exercise and Menstrual Cycle Phase in Adults with Type 1 Diabetes on Multiple Daily Insulin Injections.
- 21 Nov 2025
- Diabetes technology & therapeutics
Multivendor Continuous Glucose Monitor Integration into the Electronic Health Record: Real-World Experience of an Academic Pediatric Endocrinology Clinic.
- 21 Nov 2025
- Diabetes technology & therapeutics
The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.
- 21 Nov 2025
- Diabetes technology & therapeutics
Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed™ 780G System.
- 16 Nov 2025
- Diabetes technology & therapeutics
Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence.
- 14 Nov 2025
- Diabetes technology & therapeutics
Normal Reference Range for Glucose Rates of Change in Nondiabetic Individuals Using Continuous Glucose Monitoring.
- 21 Nov 2025
- Diabetes technology & therapeutics
Glucose Responses to Aerobic Exercise Are Influenced by Glucose Levels before the Exercise and Menstrual Cycle Phase in Adults with Type 1 Diabetes on Multiple Daily Insulin Injections.
- 21 Nov 2025
- Diabetes technology & therapeutics
Multivendor Continuous Glucose Monitor Integration into the Electronic Health Record: Real-World Experience of an Academic Pediatric Endocrinology Clinic.
- 21 Nov 2025
- Diabetes technology & therapeutics
The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.
- 21 Nov 2025
- Diabetes technology & therapeutics
Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed™ 780G System.
- 16 Nov 2025
- Diabetes technology & therapeutics
Automated Insulin Delivery Beyond Glycemic Outcomes: Endpoints and Evidence.
- 14 Nov 2025
- Diabetes technology & therapeutics
FAQs on Diabetes Technology and Therapeutics
How long has Diabetes Technology and Therapeutics been actively publishing? 
What is the publishing frequency of Diabetes Technology and Therapeutics?
How many articles did Diabetes Technology and Therapeutics publish last year?
What is the eISSN & pISSN for Diabetes Technology and Therapeutics?
What is Citescore for Diabetes Technology and Therapeutics?
What is the H Index for Diabetes Technology and Therapeutics ?
What is SNIP score for Diabetes Technology and Therapeutics?
What is the SJR for Diabetes Technology and Therapeutics?
Who is the publisher of Diabetes Technology and Therapeutics?
